Search Results - "Gestl, Shelley A"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers by Cleary, Allison S., Leonard, Travis L., Gestl, Shelley A., Gunther, Edward J.

    Published in Nature (London) (03-04-2014)
    “…In a mouse model of tumours initiated by Wnt signalling in which a proportion of tumours are biclonal, that is, composed of basal and luminal clones with…”
    Get full text
    Journal Article
  2. 2

    Different Oncogenes and Reproductive Histories Shape the Progression of Distinct Premalignant Clones in Multistage Mouse Breast Cancer Models by Linscott, Maryknoll P., Ren, Jerry R., Gestl, Shelley A., Gunther, Edward J.

    Published in The American journal of pathology (01-07-2024)
    “…A remote carcinogen exposure can predispose to breast cancer onset decades later, suggesting that carcinogen-induced mutations generate long-lived premalignant…”
    Get full text
    Journal Article
  3. 3

    A Multistage Murine Breast Cancer Model Reveals Long-Lived Premalignant Clones Refractory to Parity-Induced Protection by Li, Shuo, Gestl, Shelley A, Gunther, Edward J

    “…Breast cancers evolve in a multistage process that can span decades after a carcinogenic exposure. It follows that long-lived precursor breast lesions persist…”
    Get full text
    Journal Article
  4. 4

    Dormant Wnt-Initiated Mammary Cancer Can Participate in Reconstituting Functional Mammary Glands by Gestl, Shelley A., Leonard, Travis L., Biddle, Jessica L., Debies, Michael T., Gunther, Edward J.

    Published in Molecular and Cellular Biology (01-01-2007)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  5. 5

    Carcinogen-specific mutations in preferred Ras-Raf pathway oncogenes directed by strand bias by Keller, Ross R, Gestl, Shelley A, Lu, Amy Q, Hoke, Alicia, Feith, David J, Gunther, Edward J

    Published in Carcinogenesis (New York) (01-08-2016)
    “…Carcinogen exposures inscribe mutation patterns on cancer genomes and sometimes bias the acquisition of driver mutations toward preferred oncogenes,…”
    Get full text
    Journal Article
  6. 6

    Basal but not Luminal Mammary Epithelial Cells Require PI3K/mTOR Signaling for Ras-Driven Overgrowth by PLICHTA, Kristin A, MATHERS, Jessica L, GESTL, Shelley A, GLICK, Adam B, GUNTHER, Edward J

    Published in Cancer research (Chicago, Ill.) (15-11-2012)
    “…The mammary ducts of humans and mice are comprised of two main mammary epithelial cell (MEC) subtypes: a surrounding layer of basal MECs and an inner layer of…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Abstract A34: Mammary-specific, doxycycline-regulated transposon mobilization for identifying driver genes in mouse models of breast cancer by Gestl, Shelley A., Gunther, Edward J.

    Published in Molecular cancer research (01-11-2014)
    “…Transposon-mediated mutagenesis offers a powerful tool for discovering genetic changes that contribute to cancer pathogenesis. Tissue-specific transposon…”
    Get full text
    Journal Article
  10. 10

    Tumour cell heterogeneitymaintained by cooperating subclones in Wnt-driven mammary cancers by Cleary, Allison S, Leonard, Travis L, Gestl, Shelley A, Gunther, Edward J

    Published in Nature (London) (03-04-2014)
    “…Cancer genome sequencing studies indicate that a single breast cancer typically harbours multiple genetically distinct subclones. As carcinogenesis involves a…”
    Get full text
    Journal Article
  11. 11

    Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16Ink4a loss by Debies, Michael T., Gestl, Shelley A., Mathers, Jessica L., Mikse, Oliver R., Leonard, Travis L., Moody, Susan E., Chodosh, Lewis A., Cardiff, Robert D., Gunther, Edward J.

    Published in The Journal of clinical investigation (02-01-2008)
    “…Breast cancers frequently progress or relapse during targeted therapy, but the molecular mechanisms that enable escape remain poorly understood. We elucidated…”
    Get full text
    Journal Article
  12. 12

    Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss by Debies, Michael T, Gestl, Shelley A, Mathers, Jessica L, Mikse, Oliver R, Leonard, Travis L, Moody, Susan E, Chodosh, Lewis A, Cardiff, Robert D, Gunther, Edward J

    Published in The Journal of clinical investigation (01-01-2008)
    “…Breast cancers frequently progress or relapse during targeted therapy, but the molecular mechanisms that enable escape remain poorly understood. We elucidated…”
    Get full text
    Journal Article
  13. 13

    Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by [p19.sup.Arf]/p53 pathway lesions but not [p16.sup.Ink4a] loss by Debies, Michael T, Gestl, Shelley A, Mathers, Jessica L, Mikse, Oliver R, Leonard, Travis L, Moody, Susan E, Chodosh, Lewis A, Cardiff, Robert D, Gunther, Edward J

    Published in The Journal of clinical investigation (01-01-2008)
    “…Breast cancers frequently progress or relapse during targeted therapy, but the molecular mechanisms that enable escape remain poorly understood. We elucidated…”
    Get full text
    Journal Article
  14. 14

    Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19^sup Arf^/p53 pathway lesions but not p16^sup Ink4a^ loss by Debies, Michael T, Gestl, Shelley A, Mathers, Jessica L, Mikse, Oliver R, Leonard, Travis L, Moody, Susan E, Chodosh, Lewis A, Cardiff, Robert D, Gunther, Edward J

    Published in The Journal of clinical investigation (01-01-2008)
    “…Breast cancers frequently progress or relapse during targeted therapy, but the molecular mechanisms that enable escape remain poorly understood. We elucidated…”
    Get full text
    Journal Article